Impact of postremission consolidation chemotherapy on outcome after reduced‐intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 855-863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year‐old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 719-724

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of a fludarabine and melphalan combination‐based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 883-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high‐risk acute myeloid leukaemia and other high risk myeloid malignancies

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : E97-E100

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fludarabine, cytarabine, granulocyte colony‐stimulating factor and melphalan (FALG with L‐PAM) as a reduced toxicity conditioning regimen in children with acute leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 712-716

John Wiley & Sons Inc

Access to resources Recommend Favorite